Join to view full profile
1010 W La Veta Ave Ste 200Orange, CA 92868
Phone+1 714-835-1800
Fax+1 714-835-1811
Dr. Margileth is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineResidency, Internal Medicine, 1971 - 1973- Baylor College of MedicineClass of 1971
Certifications & Licensure
CA State Medical License 1975 - 2025
TX State Medical License 1971 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013, 2015-2017
Clinical Trials
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Jul 21
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Publications & Presentations
PubMed
- 20 citationsTumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair defi...Phillip Gray, Pei Tsai, Daniel Chen, Sitao Wu, Jayne Hoo
Oncotarget. 2018-04-17 - 36 citationsAssessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation CarriersIgnacio Blanco, Karoline Kuchenbaecker, Daniel Cuadras, Xianshu Wang, Daniel Barrowdale
Plos One. 2015-04-01 - 85 citationsHormone replacement therapy in previously treated breast cancer patients.Alan G. Wile, Richard W. Opfell, David A. Margileth
American Journal of Surgery. 1993-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
